Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | -1.60% | +4.55% | -38.87% |
05-15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
05-14 | Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.87% | 37.24M | |
-1.62% | 89.22B | |
+1.32% | 40.49B | |
-15.57% | 32.79B | |
+64.13% | 26.23B | |
-21.55% | 14.52B | |
-7.72% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- FBIO Stock
- News Fortress Biotech, Inc.
- Fortress Biotech Swings to Q3 Non-GAAP Loss, Revenue Drops